Could a simple mist replace surgery for Kids' Post-Tonsillectomy bleeding?
NCT ID NCT07565753
First seen May 07, 2026 · Last updated Jun 10, 2026 · Updated 7 times
Summary
This study tests whether a medicated mist (nebulized tranexamic acid) can safely stop bleeding in children after tonsil removal. About 30 kids aged 2 to 17 who experience bleeding will receive the mist instead of going back to the operating room. The goal is to see if this approach can avoid repeat surgery and its risks, such as anesthesia complications and emotional distress.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMORRHAGE, SURGICAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hasbro Childrens' Hospital
Providence, Rhode Island, 02903, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital
San Antonio, Texas, 78229, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of California at Davis Medical Center
Davis, California, 95819, United States
Contact Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.